2021 Student Research Conference:
34th Annual Student Research Conference

Computational Drug Discovery for a Protease Inhibitor as a Treatment for the Coronavirus Disease

Marissa D. Pina
Dr. Bill R. Miller, Faculty Mentor

COVID-19 is a global pandemic that has resulted in 2.65 million deaths worldwide. COVID-19 is caused by the novel coronavirus, SARS-CoV-2. The current study aims to find a suitable inhibitor for the main protease of SARS-CoV-2. To test for novel inhibitors, 5180 known protease inhibitors were screened using Autodock QuickVina02. The 38 inhibitors that resulted in the most favorable complexes were simulated using Amber18 Molecular Dynamics. The average binding free energies of the controls (N3, ebselen, and cinanserin) are -14.3, -17.0, and -16.2 kcal mol<sup>-1</sup>, respectively. The ligand with the best average binding free energy was optimized, and resulted in an average binding free energy of -43.9 kcal mol<sup>-1</sup>, which is a promising result since it is much lower than the average binding free energies of the controls. This work will help us find treatments capable of fighting the novel coronavirus.

Keywords: COVID-19, SARS-CoV-2, molecular dynamics, computational chemistry, inhibitor, drug discovery, main protease, coronavirus

Topic(s):Biochemistry and Molecular Biology

Presentation Type: Asynchronous Virtual Oral Presentation

Session: 3-1
Location: https://flipgrid.com/f86d186b
Time: 0:00

Add to Custom Schedule

   SRC Privacy Policy